4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-24-003312
Director bought 2,000 shares at $11.00 ($22,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| THOMAS FRANK E Director | 2024-02-14 | Purchase | +2,000 | $11.00 | $22,000 | 2,000 | D |
| Open-market purchases · 2,000 sh · avg $11.00 · $22,000 | |||||||
Loading xslF345X05/form4.xml…